Abbott reports third-quarter 2014 results
Abbott reported third-quarter 2014 worldwide sales from continuing operations of $5.1 billion increased 6.7 percent on an operational basis, and diluted EPS was $0.62 in the third quarter, representing growth of 12.7 percent, and above the previous guidance range of $0.59 to $0.61. October 22, 2014